Article
OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths.
Clinical pharmacology and therapeutics - 1 Sept 2010
Bunten H, Liang W J, Pounder D J, Seneviratne C, Osselton D
Abstract excerpt
Methadone is a medication valued for its effectiveness in the treatment of heroin addiction; however, many fatal poisonings associated with its use have been reported over the years. We have examined the association between CYP2B6 and micro-opioid receptor (OPRM1) gene variations and apparent susceptibility to methadone poisoning. Genomic DNA was extracted from postmortem whole blood of 40 individuals whose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
